PAA 5.41% 17.5¢ pharmaust limited

Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing, page-42

  1. 2,355 Posts.
    lightbulb Created with Sketch. 1440
    As NZT has stated why not be preparing all the relevant paperwork for FDA approval and the orphan drug application as the trials are running.

    A question that should be asked at the AGM.


 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
-0.010(5.41%)
Mkt cap ! $69.28M
Open High Low Value Volume
18.5¢ 18.5¢ 17.5¢ $58.74K 325.5K

Buyers (Bids)

No. Vol. Price($)
13 270003 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 116651 3
View Market Depth
Last trade - 16.10pm 21/05/2024 (20 minute delay) ?
Last
18.0¢
  Change
-0.010 ( 0.00 %)
Open High Low Volume
18.0¢ 18.0¢ 17.5¢ 141605
Last updated 15.28pm 21/05/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.